By Laura Lutz
Des Moines, July 30 - Curidium Media plc settled a private placement of shares for £2.5 million.
The company sold 100 million ordinary shares to strategic investors for 2.5p per share.
The lead investor also received options to buy 5 million ordinary shares at the same price during the next five years.
Following the placement, Curidium has 557,811,392 shares outstanding.
Proceeds will be used to expand the company business and for product development.
Curidium is a London-based pharmaceutical company focused on central nervous system diseases and its PsychINDx product, a blood diagnostic test.
| Issuer: | Curidium Media plc
|
| Issue: | Ordinary shares
|
| Amount: | £2.5 million
|
| Shares: | 100 million
|
| Price: | 2.5p
|
| Options: | For 5 million shares
|
| Option expiration: | Five years
|
| Option strike price: | 2.5p
|
| Settlement date: | July 30
|
| Stock symbol: | London: CUR
|
| Stock price: | 3p at close July 30
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
